RCM
DALS

Robinson Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Robinson Capital Management’s Portfolio DALS Stock Details DALS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-24,555
Closed -$252K – 291
2023
Q2 		$252K Sell
24,555
-445
-2% -$4.54K 0.11% 127
2023
Q1 		$254K Buy
25,000
+1,364
+6% +$13.7K 0.12% 152
2022
Q4 		$235K Buy
+23,636
New +$233K 0.12% 156

Robinson Capital Management's DALS Position: Q3 2023 in Review

Robinson Capital Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 24,555 shares — an estimated $252K sold.

Robinson Capital Management first reported a position in DALS in Q4 2022 and held it in 3 quarters. The position peaked at $254K in Q1 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Robinson Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Robinson Capital Management sold 24,555 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $252K.
  • Robinson Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 3 quarters.
  • Robinson Capital Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $254K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Robinson Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.